6 Institutions Simultaneously Develop 'Merah Putih' Vaccine
Translator
Ricky Mohammad Nugraha
Editor
Laila Afifa
Jumat, 30 Oktober 2020 15:14 WIB
TEMPO.CO, Jakarta - The Minister of Research and Technology, Bambang Brodjonegoro, said that there are currently six institutions that are developing Indonesia’s own COVID-19 vaccine dubbed the ‘Merah Putih' vaccine.
The six institutions are the Eijkman Institute of Molecular Biology, the Indonesian Institute of Sciences (LIPI), Gadjah Mada University, University of Indonesia, the Bandung Institute of Technology, and the Airlangga University.
“The institution that may provide it the soonest is the one developed by Eijkman as it is set to enter the animal testing stage this October,” wrote Bambang in a written release on the government website setkab.go.id on October 29. “We hope it will be completed with satisfying results by the end of this year.”
The vaccine seeds that are tested on the animal subjects will then be handed to Bio Farma that will, later on, be responsible for the small scale production for the need of the first, second, and third clinical trial. The lengthy phase of trials will assure the safety of the future COVID-19 vaccine.
Read: 'Merah Putih' COVID-19 Vaccine; Govt Considering Export Potential
CAESAR AKBAR
